Literature DB >> 17852867

Association between CDH1 haplotypes and gastric cancer risk in a Japanese population.

Hidetaka Yamada1, Kazuya Shinmura, Shinobu Ikeda, Hong Tao, Tetsuya Otani, Tomoyuki Hanaoka, Toshihiro Tsuneyoshi, Shoichiro Tsugane, Haruhiko Sugimura.   

Abstract

OBJECTIVE: A c. -285C >A single nucleotide polymorphism (SNP) in the promoter region of the E-cadherin (CDH1) gene, which is a tumor suppressor in gastric cancer (GC), has been shown to decrease gene transcription, but GC case-control studies of this SNP have yielded controversial results. A haplotype study in an Italian population showed that haplotypes based on three SNPs, including the c. -285C >A, are associated with susceptibility to GC. Hence, the purpose of the present study was to carry out a more comprehensive genetic analysis of CDH1 using haplotype-tagging SNPs (htSNPs) in a Japanese case-control study to identify the CDH1 haplotype associated with susceptibility to GC in a Japanese population.
MATERIAL AND METHODS: First, 11 SNPs in the CDH1 gene were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis in 30 healthy individuals. Haplotype frequencies were estimated with the expectation-maximization algorithm, and 7 common haplotypes of the CDH1 gene whose frequency was at least 3.3% were identified. Next, 5 htSNPs (c. -285C >A, c.48+6T >C, c.164 -3159T >C, c.2076C >T, and c.2296 -616G >C) were genotyped in a hospital-based case-control study of 148 GC patients and 292 age- and gender-matched healthy controls, and haplotype frequencies based on the 5 htSNPs were estimated.
RESULTS: Although none of the 5 htSNPs was related to an overall risk of GC, frequencies of the ATCTG and CTTTG haplotypes were significantly higher and lower, respectively, in the GC cases than in the controls (p<0.05).
CONCLUSIONS: These results suggest that the ATCTG and CTTTG CDH1 haplotypes may be associated with an increased risk and decreased risk, respectively, of GC in the Japanese population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17852867     DOI: 10.1080/00365520701478436

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  12 in total

1.  CDH1 gene polymorphisms, plasma CDH1 levels and risk of gastric cancer in a Chinese population.

Authors:  Zhen Zhan; Juan Wu; Jun-Feng Zhang; Ya-Ping Yang; Shujuan Tong; Chun-Bing Zhang; Jin Li; Xue-Wen Yang; Wei Dong
Journal:  Mol Biol Rep       Date:  2012-04-26       Impact factor: 2.316

2.  CDH1 promoter polymorphism and stomach cancer susceptibility.

Authors:  Yi-Ling Li; Zhong Tian; Jian-Bing Zhang; Bao-Yu Fu
Journal:  Mol Biol Rep       Date:  2011-05-31       Impact factor: 2.316

3.  Association between E-cadherin (CDH1) polymorphisms and papillary thyroid carcinoma risk in Han Chinese population.

Authors:  Ying-Xue Wang; Lei Zhao; Xiu-Yun Wang; Chang-Mei Liu; Su-Guo Yu
Journal:  Endocrine       Date:  2011-12-23       Impact factor: 3.633

4.  Association between E-cadherin (CDH1) polymorphisms and pancreatic cancer risk in Han Chinese population.

Authors:  Lei Zhao; Ying-Xue Wang; Mian Xi; Shi-Liang Liu; Peng Zhang; Li-Ling Luo; Meng-Zhong Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

5.  Association of E-cadherin (CDH1) gene polymorphisms and gastric cancer risk.

Authors:  Mansour S Al-Moundhri; Manal Al-Khanbashi; Mohammed Al-Kindi; Maryam Al-Nabhani; Ikram A Burney; Abdulaziz Al-Farsi; Bassim Al-Bahrani
Journal:  World J Gastroenterol       Date:  2010-07-21       Impact factor: 5.742

Review 6.  Perspectives on new biomarkers in gastric cancer: diagnostic and prognostic applications.

Authors:  Danilo do Rosário Pinheiro; Wallax Augusto Silva Ferreira; Mariceli Baia Leão Barros; Mariana Diniz Araújo; Symara Rodrigues-Antunes; Bárbara do Nascimento Borges
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

7.  Contribution of the -160C/A polymorphism in the E-cadherin promoter to cancer risk: a meta-analysis of 47 case-control studies.

Authors:  Lin Wang; Guiying Wang; Chenqi Lu; Bo Feng; Jiuhong Kang
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

8.  Association of genetic variants in and promoter hypermethylation of CDH1 with gastric cancer: a meta-analysis.

Authors:  Huiquan Jing; Fei Dai; Chuntao Zhao; Juan Yang; Lizhuo Li; Pravina Kota; Lijuan Mao; Kaimin Xiang; Changqing Zheng; Jingyun Yang
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

9.  Absence of germline mono-allelic promoter hypermethylation of the CDH1 gene in gastric cancer patients.

Authors:  Hidetaka Yamada; Kazuya Shinmura; Masanori Goto; Moriya Iwaizumi; Hiroyuki Konno; Hideki Kataoka; Masami Yamada; Takachika Ozawa; Toshihiro Tsuneyoshi; Fumihiko Tanioka; Haruhiko Sugimura
Journal:  Mol Cancer       Date:  2009-08-12       Impact factor: 27.401

10.  A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: a case control study in an Italian population.

Authors:  Soroush Nasri; Helen More; Francesco Graziano; Annamaria Ruzzo; Emily Wilson; Anita Dunbier; Cushla McKinney; Tony Merriman; Parry Guilford; Mauro Magnani; Bostjan Humar
Journal:  BMC Cancer       Date:  2008-05-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.